Login


TI Ref No : 509180432
Description : Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For Medicinal Products Containing The Active Ingredient Omalizumab (atc Code
Date : 2024-10-09
Deadline : 2026-09-27
Document Type : Tenders
View Details
Whats app